N-Formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe) and leukotriene B4 (LTB4) induce disparate second-messenger generation and functional responses in neutrophils and HL-60 granulocytes. Receptors for these chemoattractants couple to a common pool of G-proteins which are substrates for both pertussis-toxin-and cholera-toxin-catalysed ADP-ribosylation. The hypothesis that formyl-peptide and LTB4 receptors induce different receptor-specific conformations of activated Gproteins was tested. The ability of pertussis toxin and cholera toxin to ADP-ribosylate Gi proteins coupled to formyl-peptide or LTB4 receptors in membranes isolated from granulocytes was used to assess the conformational state of the a subunits. Cholera-toxin-catalysed ADP-ribosylation of a40 (40 kDa a subunit) was inhibited by guanosine 5'-[/8y-
INTRODUCTION
Polymorphonuclear leucocytes (PMNs) are capable of migrating to a site of inflammation and then releasing lysosomal enzymes or undergoing a respiratory burst when stimulated by a heterogeneous group of agonists termed chemoattractants. This group of agonists consists of peptide chemoattractants, including formylated peptides, C5a and interleukin 8, and lipid chemoattractants, including leukotriene B4 (LTB4) and plateletactivating factor (PAF). Chemoattractants differ in their ability to stimulate PMN responses. Formylated peptides and C5a are potent stimuli of the respiratory burst, whereas LTB4is relatively impotent [1] [2] [3] [4] [5] [6] [7] . Disparate functional responses are associated with differences in second-messenger generation. Specifically, phospholipase D generation of diacylglycerol is more transient and quantitatively smaller after LTB4 and PAF stimulation compared with that resulting from N-formylmethionyl-leucylphenylalanine (fMet-Leu-Phe) stimulation [3, 8, 9] . The molecular basis for disparate PMN second-messenger generation and functional responses to different chemoattractants is not known.
Current evidence indicates that chemoattractants stimulate PMN activation through G-protein-coupled signalling pathways [10] [11] [12] [13] [14] [15] [16] [17] [18] . We have shown previously that formyl-peptide and LTB4 receptors stimulate GTP hydrolysis and guanosine 5'-[ythio]triphosphate (GTP [S] ) binding in membranes prepared from HL-60 granulocytes [6] . G-protein activation by fMet-Leu-Phe and LTB4 in these membranes was inhibited by pretreatment with either pertussis toxin or cholera toxin. We used receptorspecific cholera-toxin-catalysed ADP-ribosylation, described by Gierschik and Jakobs [19] , to show that fMet-Leu-Phe and LTB4 receptors coupled to common G-proteins. However, whereas imido]triphosphate and GDP in a concentration-dependent manner. Addition of fMet-Leu-Phe, but not LTB4, re-established cholera-toxin labelling of a40 in the presence of either guanine nucleotide. In the absence of guanine nucleotides, fMet-Leu-Phe and C5a enhanced cholera-toxin-catalysed labelling of cc40, whereas LTB4 and platelet-activating factor had no effect. fMet-Leu-Phe stimulated receptor-specific cholera-toxin labelling, LTB4 lacked this activity [6] . One hypothesis which could explain these findings is the ability of activated G-proteins to exist in different receptor-specific conformations. In the present study, the ability of pertussis toxin and cholera toxin to ADP-ribosylate G-proteins coupled to formyl-peptide or LTB4 receptors in membranes isolated from HL-60 granulocytes was used to assess the conformational state of these G-proteins [20] [21] [22] [23] . The ability of G. to act as a substrate for these toxins was modulated by the presence of guanine nucleotides and fMet-Leu-Phe or LTB4. The data support the hypothesis that formyl-peptide and LTB4 receptors induce different conformations of activated cc, (a subunit of G1). [24] .
MATERIALS AND METHODS
[32P]ADP-ribosylation by cholera toxin Cholera toxin ( (Figure 2b) . Second, the ability of fMet-Leu-Phe and LTB4, as well as C5a and PAF, to enhance cholera-toxin-catalysed ADP-ribosylation of a0 in the absence of added guanine nucleotides was examined.
Figure 3 demonstrates that fMet-Leu-Phe and C5a stimulate enhanced labelling, whereas cholera-toxin labelling in the presence of LTB4 and PAF is unchanged.
Receptor-specific alterations in pertussis-toxin labelling of G1 [19, 26] . Gierschik and Jakobs [19] reported that labelling of the 40 kDa subunit was inhibited by 100 ,M p[NH]ppG, but labelling was re-established in the presence of fMet-Leu-Phe [19] . We utilized this receptor-specific cholera-toxin-catalysed ADP-ribosylation to compare the ability of fMet-Leu-Phe and LTB4 to enhance labelling of c40' As shown in Figure 1 and reported previously [6] , fMet-Leu-Phe reestablished labelling of a40 in a concentration-dependent manner, whereas LTB4 failed to re-establish cholera-toxin labelling of a4O.
One possible explanation for the failure of LTB4 to re-establish cholera-toxin labelling is that LTB4 receptors are less effective in stimulating guanine nucleotide release. We have shown that Gproteins activated by fMet-Leu-Phe receptors demonstrate a significantly lower affinity for GDP than those activated by'LTB4 receptors [27] . Figure 4 demonstrates that fMet-Leu-Phe inhibited pertussis-toxin labelling by 350% in the presence of 10 laM GTP[S], whereas LTB4 had no effect. The combination of fMetLeu-Phe and LTB4 resulted in a decrease in labelling, similar to that seen with fMet-Leu-Phe alone. The ability of fMet-Leu-Phe and LTB4 to alter pertussis-toxin labelling of a40 in the presence or absence of GDP is shown in Figure 5 , and the computer-assisted analysis of densitometric scanning of the autoradiograms is shown in Table 
DISCUSSION
Pertussis toxin and cholera toxin covalently label some Gprotein a subunits. Pertussis toxin catalyses ADP-ribosylation of a cysteine residue four amino acids from the C-terminus of a, ao and ai (reviewed in [30] ). The site of cholera-toxin-catalysed ADP-ribosylation is an arginine residue at position 179 and 178 on ai2 and ai3 respectively [31] . In HL-60 granulocyte membranes, pertussis toxin and cholera toxin ADP-ribosylate a subunits which migrate at about 40 kDa [6, 19, 24, 32] . The two toxins label the same a subunits, as exposure of intact HL-60 granulocytes to pertussis toxin prevents subsequent ADPribosylation of isolated membranes by cholera toxin [19, 26] . Thus the two toxins require access to two different sites on the same G-proteins in HL-60 granulocytes for ADP-ribosylation to occur.
The mechanism by which G-proteins relay signals from receptors to effectors depends on cyclic conformational changes in the a subunit related to the binding of receptors and different guanine nucleotides [33] [34] [35] . Alterations in G-protein conformation by guanine nucleotides lead to altered susceptibility of Gi to ADP-ribosylation by pertussis and cholera toxins [19] [20] [21] [22] [23] [35] [36] [37] . The present study confirms that, in the absence of guanine nucleotides, cholera toxin catalyses ADP-ribosylation of ai in membranes from HL-60 granulocytes, whereas p[NH]ppG inhibits cholera-toxin labelling of a; [19, 26] . We show that GDP also inhibits cholera-toxin-catalysed ADP-ribosylation of ax in a dose-dependent manner. Thus the optimal state for Gi to serve as substrate for cholera-toxin labelling appears to be with an empty guanine-nucleotide-binding site. Previous reports showed that GDP enhances, whereas GTP[S] inhibits, pertussistoxin-catalysed ADP-ribosylation of a, [21] [22] [23] 36] . The ability of guanine nucleotides to alter pertussis-toxin-and choleratoxin-induced ADP-ribosylation of ai indicates that various conformations of these a subunits can be detected in HL-60 granulocyte membranes. We used alterations in toxin-induced labelling to examine the conformations of a, coupled to ligandbound formyl-peptide and LTB4 receptors.
The ability of fMet-Leu-Phe to alter pertussis-toxin-and cholera-toxin-induced labelling of ac indicates that receptorspecific conformational changes can be detected in HL-60 granulocyte membranes. Receptor-specific cholera-toxin labelling has been reported for formyl peptides in HL-60 cell membranes by Gierschik and co-workers [19, 26] and for opioid peptides in NG108-15 cells by Milligan and McKenzie [37] .
Preincubation of membranes with fMet-Leu-Phe in our study decreased pertussis-toxin-catalysed ADP-ribosylation in the absence of guanine nucleotides or in the presence of GTP[S] and enhanced pertussis-toxin labelling of cx in the presence of GDP.
Rothenberg and Kahn [20] showed that insulin decreased pertussis-toxin labelling of G-proteins on liver cell membranes in the absence of guanine nucleotides. Tsai et al. [21] reported that photolysed rhodopsin decreased pertussis-toxin labelling of ai in the absence of guanine nucleotides and enhanced labelling in the presence of GDP. Preincubation of thyroid cell membranes with thyrotropin has been shown to decrease pertussis-toxin labelling of Gi in the absence of guanine nucleotides [28, 29] .
Differences in the ability of fMet-Leu-Phe and LTB4 to alter pertussis-toxin-and cholera-toxin-induced labelling of cx indicate that formyl-peptide and LTB4 receptors induce different conformations of receptor-coupled G, proteins. LTB4 failed to restore cholera-toxin labelling in the presence of p[NH]ppG or GDP, and LTB4 failed to enhance cholera-toxin labelling of ai in the absence of guanine nucleotides. Receptor-specific choleratoxin-catalysed labelling of ai was not unique to fMet-Leu-Phe, as C5a also enhanced ac labelling. Interestingly, PAF failed to enhance cholera-toxin-induced labelling, suggesting that there may be a fundamental difference between receptors for peptide and lipid chemoattractants. Similarly to the differences between fMet-Leu-Phe and LTB4 in the presence of cholera toxin, LTB4 did not decrease pertussis-toxin labelling of ac in the absence of guanine nucleotides or in the presence of GTP [S] .
We have reported previously that fMet-Leu-Phe receptors induce a lower affinity of guanine-nucleotide-binding sites for GDP than do LTB4 receptors [27] . This finding suggests that differences in the ability of fMet-Leu-Phe and LTB4 to alter ADP-ribosylation may be due to differences in the rate of release of p[NH]ppG or GDP from guanine-nucleotide-binding sites. However, the ability of fMet-Leu-Phe, but not LTB4, to alter toxin-catalysed labelling of Gi in the absence of guanine nucleotides indicates that differences in receptor-specific Gprotein conformations induced by fMet-Leu-Phe and LTB4 are not likely to be due only to differences in guanine-nucleotidebinding site affinity. Our interpretation of these results is that both the difference in guanine-nucleotide-binding site affinity and the difference in receptor-specific toxin labelling are due to different receptor-specific conformations of G1. Additionally, the ability of LTB4 and fMet-Leu-Phe to enhance pertussis-toxin labelling in the presence of GDP shows that LTB4-receptorinduced conformational changes in a, are detectable by differences in toxin labelling under the appropriate conditions.
We conclude that formyl-peptide and LTB4 receptors induce different conformations of Gi after ligand binding. Gierschik et al. [26] reported that formyl-peptide receptors are coupled to both Gi2 and G13 proteins in HL-60 granulocyte membranes.
Our data do not address the question of whether formyl-peptide and LTB4 receptors induce different conformations of both xi2 and cx3. Our results suggest that activated G-proteins can exist in multiple conformations determined by the receptors with which they interact. The functional consequences of receptorspecific conformations of activated G-proteins are unknown. The possibility exists that these differences may provide one explanation for the different capabilities of formyl-peptide and LTB4 receptors to activate effector enzymes.
